124 related articles for article (PubMed ID: 36055117)
1. Lab resource: Single cell line generation and characterization of a human-derived induced pluripotent stem cell line (IGIBi005-A) from a patient with spastic paraplegia/ataxia/ALS phenotype due to the mutation of the gene Kinesin Family Member 5A (KIF5A).
Ahmad I; Goel D; Ghosh A; Kapoor H; Kumar D; Srivastava AK; Faruq M
Stem Cell Res; 2022 Oct; 64():102904. PubMed ID: 36055117
[TBL] [Abstract][Full Text] [Related]
2. Generation of an iPSC line from a patient with spastic paraplegia type 10 carrying a novel mutation in KIF5A gene.
Santangelo S; Bossolasco P; Magri S; Colombrita C; Invernizzi S; Gellera C; Nanetti L; Di Bella D; Silani V; Taroni F; Ratti A
Stem Cell Res; 2023 Feb; 66():103008. PubMed ID: 36565680
[TBL] [Abstract][Full Text] [Related]
3. Hot-spot KIF5A mutations cause familial ALS.
Brenner D; Yilmaz R; Müller K; Grehl T; Petri S; Meyer T; Grosskreutz J; Weydt P; Ruf W; Neuwirth C; Weber M; Pinto S; Claeys KG; Schrank B; Jordan B; Knehr A; Günther K; Hübers A; Zeller D; Kubisch C; Jablonka S; Sendtner M; Klopstock T; de Carvalho M; Sperfeld A; Borck G; Volk AE; Dorst J; Weis J; Otto M; Schuster J; Del Tredici K; Braak H; Danzer KM; Freischmidt A; Meitinger T; Strom TM; Ludolph AC; Andersen PM; Weishaupt JH;
Brain; 2018 Mar; 141(3):688-697. PubMed ID: 29342275
[TBL] [Abstract][Full Text] [Related]
4. Expanding the spectrum of
Dulski J; Strongosky AJ; Al-Shaikh RH; Wszolek ZK
Amyotroph Lateral Scler Frontotemporal Degener; 2023 May; 24(3-4):347-350. PubMed ID: 36604770
[TBL] [Abstract][Full Text] [Related]
5. Genotype-phenotype correlations of
de Boer EMJ; van Rheenen W; Goedee HS; Kamsteeg EJ; Brilstra EH; Veldink JH; van Den Berg LH; van Es MA
Amyotroph Lateral Scler Frontotemporal Degener; 2021 Nov; 22(7-8):561-570. PubMed ID: 33829936
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide Analyses Identify KIF5A as a Novel ALS Gene.
Nicolas A; Kenna KP; Renton AE; Ticozzi N; Faghri F; Chia R; Dominov JA; Kenna BJ; Nalls MA; Keagle P; Rivera AM; van Rheenen W; Murphy NA; van Vugt JJFA; Geiger JT; Van der Spek RA; Pliner HA; Shankaracharya ; Smith BN; Marangi G; Topp SD; Abramzon Y; Gkazi AS; Eicher JD; Kenna A; ; Mora G; Calvo A; Mazzini L; Riva N; Mandrioli J; Caponnetto C; Battistini S; Volanti P; La Bella V; Conforti FL; Borghero G; Messina S; Simone IL; Trojsi F; Salvi F; Logullo FO; D'Alfonso S; Corrado L; Capasso M; Ferrucci L; ; Moreno CAM; Kamalakaran S; Goldstein DB; ; Gitler AD; Harris T; Myers RM; ; Phatnani H; Musunuri RL; Evani US; Abhyankar A; Zody MC; ; Kaye J; Finkbeiner S; Wyman SK; LeNail A; Lima L; Fraenkel E; Svendsen CN; Thompson LM; Van Eyk JE; Berry JD; Miller TM; Kolb SJ; Cudkowicz M; Baxi E; ; Benatar M; Taylor JP; Rampersaud E; Wu G; Wuu J; ; Lauria G; Verde F; Fogh I; Tiloca C; Comi GP; Sorarù G; Cereda C; ; Corcia P; Laaksovirta H; Myllykangas L; Jansson L; Valori M; Ealing J; Hamdalla H; Rollinson S; Pickering-Brown S; Orrell RW; Sidle KC; Malaspina A; Hardy J; Singleton AB; Johnson JO; Arepalli S; Sapp PC; McKenna-Yasek D; Polak M; Asress S; Al-Sarraj S; King A; Troakes C; Vance C; de Belleroche J; Baas F; Ten Asbroek ALMA; Muñoz-Blanco JL; Hernandez DG; Ding J; Gibbs JR; Scholz SW; Floeter MK; Campbell RH; Landi F; Bowser R; Pulst SM; Ravits JM; MacGowan DJL; Kirby J; Pioro EP; Pamphlett R; Broach J; Gerhard G; Dunckley TL; Brady CB; Kowall NW; Troncoso JC; Le Ber I; Mouzat K; Lumbroso S; Heiman-Patterson TD; Kamel F; Van Den Bosch L; Baloh RH; Strom TM; Meitinger T; Shatunov A; Van Eijk KR; de Carvalho M; Kooyman M; Middelkoop B; Moisse M; McLaughlin RL; Van Es MA; Weber M; Boylan KB; Van Blitterswijk M; Rademakers R; Morrison KE; Basak AN; Mora JS; Drory VE; Shaw PJ; Turner MR; Talbot K; Hardiman O; Williams KL; Fifita JA; Nicholson GA; Blair IP; Rouleau GA; Esteban-Pérez J; García-Redondo A; Al-Chalabi A; ; Rogaeva E; Zinman L; Ostrow LW; Maragakis NJ; Rothstein JD; Simmons Z; Cooper-Knock J; Brice A; Goutman SA; Feldman EL; Gibson SB; Taroni F; Ratti A; Gellera C; Van Damme P; Robberecht W; Fratta P; Sabatelli M; Lunetta C; Ludolph AC; Andersen PM; Weishaupt JH; Camu W; Trojanowski JQ; Van Deerlin VM; Brown RH; van den Berg LH; Veldink JH; Harms MB; Glass JD; Stone DJ; Tienari P; Silani V; Chiò A; Shaw CE; Traynor BJ; Landers JE
Neuron; 2018 Mar; 97(6):1267-1288. PubMed ID: 29566793
[TBL] [Abstract][Full Text] [Related]
7. ALS-linked KIF5A ΔExon27 mutant causes neuronal toxicity through gain-of-function.
Pant DC; Parameswaran J; Rao L; Loss I; Chilukuri G; Parlato R; Shi L; Glass JD; Bassell GJ; Koch P; Yilmaz R; Weishaupt JH; Gennerich A; Jiang J
EMBO Rep; 2022 Aug; 23(8):e54234. PubMed ID: 35735139
[TBL] [Abstract][Full Text] [Related]
8. Generation of three spinocerebellar ataxia type-12 patients derived induced pluripotent stem cell lines (IGIBi002-A, IGIBi003-A and IGIBi004-A).
Kumar D; Hussain A; Srivastava AK; Mukerji M; Mukherjee O; Faruq M
Stem Cell Res; 2018 Aug; 31():216-221. PubMed ID: 30130680
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneous splicing patterns resulting from KIF5A variants associated with amyotrophic lateral sclerosis.
Pino MG; Rich KA; Hall NJ; Jones ML; Fox A; Musier-Forsyth K; Kolb SJ
Hum Mol Genet; 2023 Nov; 32(22):3166-3180. PubMed ID: 37593923
[TBL] [Abstract][Full Text] [Related]
10. ALS-Associated KIF5A Mutation Causes Locomotor Deficits Associated with Cytoplasmic Inclusions, Alterations of Neuromuscular Junctions, and Motor Neuron Loss.
Soustelle L; Aimond F; López-Andrés C; Brugioti V; Raoul C; Layalle S
J Neurosci; 2023 Nov; 43(47):8058-8072. PubMed ID: 37748861
[TBL] [Abstract][Full Text] [Related]
11. Intrafamilial variable spastic paraplegia/ataxia/ALS phenotype linked to a novel KIF5A mutation.
Faruq M; Kumar D; Wadhwa S; Shamim U; Mathur A; Parveen S; Garg A; Srivastava AK
Clin Genet; 2019 Sep; 96(3):271-273. PubMed ID: 31286494
[No Abstract] [Full Text] [Related]
12. Impaired motor unit recovery and maintenance in a knock-in mouse model of ALS-associated Kif5a variant.
Rich KA; Pino MG; Yalvac ME; Fox A; Harris H; Balch MHH; Arnold WD; Kolb SJ
Neurobiol Dis; 2023 Jun; 182():106148. PubMed ID: 37164288
[TBL] [Abstract][Full Text] [Related]
13. An ALS-associated KIF5A mutant forms oligomers and aggregates and induces neuronal toxicity.
Nakano J; Chiba K; Niwa S
Genes Cells; 2022 Jun; 27(6):421-435. PubMed ID: 35430760
[TBL] [Abstract][Full Text] [Related]
14. Generation of 3 spinocerebellar ataxia type 1 (SCA1) patient-derived induced pluripotent stem cell lines LUMCi002-A, B, and C and 2 unaffected sibling control induced pluripotent stem cell lines LUMCi003-A and B.
Buijsen RAM; Gardiner SL; Bouma MJ; van der Graaf LM; Boogaard MW; Pepers BA; Eussen B; de Klein A; Freund C; van Roon-Mom WMC
Stem Cell Res; 2018 May; 29():125-128. PubMed ID: 29656178
[TBL] [Abstract][Full Text] [Related]
15. Genetic and functional analysis of KIF5A variants in Japanese patients with sporadic amyotrophic lateral sclerosis.
Nakamura R; Tohnai G; Atsuta N; Nakatochi M; Hayashi N; Watanabe H; Yokoi D; Watanabe H; Katsuno M; Izumi Y; Taniguchi A; Kanai K; Morita M; Kano O; Kuwabara S; Oda M; Abe K; Aoki M; Aiba I; Okamoto K; Mizoguchi K; Hattori N; Nakashima K; Kaji R; Sobue G;
Neurobiol Aging; 2021 Jan; 97():147.e11-147.e17. PubMed ID: 32888732
[TBL] [Abstract][Full Text] [Related]
16. Generation of two induced pluripotent stem cell lines with heterozygous and homozygous amyotrophic lateral sclerosis-causing mutation R521G (c.1561C > G) in FUS gene.
Akter M; Cui H; Abir Hosain M; Ding B
Stem Cell Res; 2023 Jun; 69():103078. PubMed ID: 36965406
[TBL] [Abstract][Full Text] [Related]
17. Generation and characterization of a human iPSC line from an ALS patient carrying the Q66K-MATR3 mutation.
Pollini D; Loffredo R; Cardano M; Conti L; Lattante S; Notarangelo A; Sabatelli M; Provenzani A
Stem Cell Res; 2018 Dec; 33():146-150. PubMed ID: 30366341
[TBL] [Abstract][Full Text] [Related]
18. ALS-associated KIF5A mutations abolish autoinhibition resulting in a toxic gain of function.
Baron DM; Fenton AR; Saez-Atienzar S; Giampetruzzi A; Sreeram A; Shankaracharya ; Keagle PJ; Doocy VR; Smith NJ; Danielson EW; Andresano M; McCormack MC; Garcia J; Bercier V; Van Den Bosch L; Brent JR; Fallini C; Traynor BJ; Holzbaur ELF; Landers JE
Cell Rep; 2022 Apr; 39(1):110598. PubMed ID: 35385738
[TBL] [Abstract][Full Text] [Related]
19. Generation of two induced pluripotent stem cell (iPSC) lines from an ALS patient with simultaneous mutations in KIF5A and MATR3 genes.
Medina DX; Boehringer A; Dominick M; Lorenzini I; Saez-Atienzar S; Pioro EP; Sattler R; Traynor B; Bowser R
Stem Cell Res; 2020 Dec; 50():102141. PubMed ID: 33388707
[TBL] [Abstract][Full Text] [Related]
20. Generation of a human induced pluripotent stem cell line (SDUBMSi001-A) from a hereditary spastic paraplegia patient carrying kif1a c.773C>T missense mutation.
Xiaojing W; Yanyan M; Ruonan D; Xiaolin L; Haiyan Z; Jian M; Yi L; Wenjie S; Qiji L
Stem Cell Res; 2020 Mar; 43():101727. PubMed ID: 32045731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
